
nference
nference
nference
Making biomedical knowledge computable
Making biomedical knowledge computable
Making biomedical knowledge computable
Biotechnology Research
Biotechnology Research
⋅
⋅
Cambridge
Cambridge
US
US
⋅
⋅
201–500 employees
201–500 employees
⋅
⋅
Founded:
Founded:
January 2013
January 2013
Overview
Overview
nference leverages the top academic minds, world-class researchers, and real-time access to multimodal, patient-level data to accelerate drug development innovation, generate evidence, and improve clinical trial processes. nSights, our flagship software platform, delivers the most comprehensive biological and clinical insights into patient care.
nference leverages the top academic minds, world-class researchers, and real-time access to multimodal, patient-level data to accelerate drug development innovation, generate evidence, and improve clinical trial processes. nSights, our flagship software platform, delivers the most comprehensive biological and clinical insights into patient care.
Founder
Founder
Murali Aravamudan
Murali Aravamudan
Founder and CEO at nference
Founder and CEO at nference
Hiring Trend
Hiring Trend
TOTAL hires
TOTAL hires
17
17
Employee Growth
Employee Growth
TOTAL EMPLOYEES
TOTAL EMPLOYEES
315
315
6m GROWTH
6m GROWTH
1y GROWTH
1y GROWTH
-1%
-1%
Department Distribution
Department Distribution
TOTAL EMPLOYEES
TOTAL EMPLOYEES
315
315
Engineering
Engineering
Research
Research
Information Technology
Information Technology
Operations
Operations
Business Development
Business Development
Department Growth
Department Growth
6m GROWTH
6m GROWTH
1y GROWTH
1y GROWTH
Engineering
-3%
-7%
Research
0%
10%
Information Technology
-12%
-4%
Operations
14%
7%
Business Development
-13%
0%
Web Engagement
pages per visit
pages per visit
1.7
1.7
monthly visits
monthly visits
5,775
5,775
Web Traffic by Country
Web Traffic by Country
United States
59.9%
United States
59.9%
India
40.1%
India
40.1%
Web Traffic Sources
Web Traffic Sources
Direct
39%
Direct
39%
Search
34.2%
Search
34.2%
Social
6.3%
Social
6.3%
Referrals
10%
Referrals
10%
AI
1.8%
AI
1.8%
funding round
6
last round type
NON_EQUITY_ASSISTANCE
announced on
funding round
6
last round type
NON_EQUITY_ASSISTANCE
announced on

A network graph of your entire TAM. We find the path into every account worth a meeting, and book it.
A network graph of your entire TAM. We find the path into every account worth a meeting, and book it.


© 2026 InGrow. All rights reserved.
© 2026 InGrow. All rights reserved.


